Skip to main content


FS visits biomedical firm in UK

Financial Secretary Paul Chan yesterday visited a biopharmaceutical company and the Royal College of Art, and attended a lunch hosted by the China-Britain Business Council, as part of his ongoing trip to London.   Mr Chan visited AstraZeneca and met the company’s senior management to learn about its drug research and development activities, as well as its latest expansion plans.   AstraZeneca indicated that following in-depth talks with Hong Kong’s Office for Attracting Strategic Enterprises, it plans to develop a research and development centre in Hong Kong and will engage in further discussion with relevant government departments on the matter.   The Financial Secretary then attended a roundtable luncheon held by the China-Britain Business Council, and met representatives of British enterprises that do business, or plan to do business, either in the Mainland or Hong Kong.   Mr Chan later visited the Royal College of Art, which collaborated with the Hong Kong Polytechnic Unive

Mainland study scheme opens

The Mainland University Study Subsidy Scheme 2023-24 is open for applications from Hong Kong students until September 8, the Education Bureau announced today.   Covering 193 designated Mainland institutions, 132 of which participated in the 2023-24 Scheme for Admission of Hong Kong Students to Mainland Higher Education Institutions, the subsidy scheme is of most benefit to local students from financially disadvantaged backgrounds who wish to pursue undergraduate studies in the Mainland.   While the scheme is not subject to any quota system, applicants may only receive either a means-tested subsidy or a non-means-tested subsidy in the same academic year.   The subsidy is granted on a yearly basis and the subsidised period covers the normal duration of the undergraduate programme pursued by the student concerned.   Eligible students may enrol online or by post. Application results are expected to be released by the first quarter of 2024.

Popular Posts